Literature DB >> 32202164

Expression and purification of amyloid β-protein, tau, and α-synuclein in Escherichia coli: a review.

Longgang Jia1,2, Wenping Zhao1, Wei Wei1, Xiao Guo1, Wenjuan Wang1, Ying Wang1, Jingcheng Sang1, Fuping Lu1, Fufeng Liu1.   

Abstract

Misfolding and accumulation of amyloidogenic proteins into various forms of aggregated intermediates and insoluble amyloid fibrils is associated with more than 50 human diseases. Large amounts of high-quality amyloid proteins are required for better probing of their aggregation and neurotoxicity. Due to their intrinsic hydrophobicity, it is a challenge to obtain amyloid proteins with high yield and purity, and they have attracted the attention of researchers from all over the world. The rapid development of bioengineering technology provides technical support for obtaining large amounts of recombinant amyloidogenic proteins. This review discusses the available expression and purification methods for three amyloid proteins including amyloid β-protein, tau, and α-synuclein in microbial expression systems, especially Escherichia coli, and discusses the advantages and disadvantages of these methods. Importantly, these protocols can also be referred to for the expression and purification of other hydrophobic proteins.

Entities:  

Keywords:  E. coli expression system; Protein conformational disease; amyloid protein; heterogenous protein expression; purification

Year:  2020        PMID: 32202164     DOI: 10.1080/07388551.2020.1742646

Source DB:  PubMed          Journal:  Crit Rev Biotechnol        ISSN: 0738-8551            Impact factor:   8.429


  3 in total

1.  In vivo liquid-liquid phase separation protects amyloidogenic and aggregation-prone peptides during overexpression in Escherichia coli.

Authors:  Bartosz Gabryelczyk; Reema Alag; Margaret Philips; Kimberly Low; Anandalakshmi Venkatraman; Bhuvaneswari Kannaian; Xiangyan Shi; Markus Linder; Konstantin Pervushin; Ali Miserez
Journal:  Protein Sci       Date:  2022-05       Impact factor: 6.725

Review 2.  Hypoxia and the Kynurenine Pathway: Implications and Therapeutic Prospects in Alzheimer's Disease.

Authors:  Oluyomi Stephen Adeyemi; Oluwakemi Josephine Awakan; Lawrence Boluwatife Afolabi; Damilare Emmanuel Rotimi; Elizabeth Oluwayemi; Chiagoziem A Otuechere; Omodele Ibraheem; Tobiloba Chritiana Elebiyo; Omokolade Alejolowo; Afolake T Arowolo
Journal:  Oxid Med Cell Longev       Date:  2021-11-10       Impact factor: 6.543

3.  Fast Purification of Recombinant Monomeric Amyloid-β from E. coli and Amyloid-β-mCherry Aggregates from Mammalian Cells.

Authors:  Amberley D Stephens; Meng Lu; Ana Fernandez-Villegas; Gabriele S Kaminski Schierle
Journal:  ACS Chem Neurosci       Date:  2020-10-02       Impact factor: 4.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.